High C-reactive protein and low cholesterol levels are prognostic markers of survival in severe sepsis
Journal of Clinical Anesthesia, cilt.19, sa.3, ss.186-191, 2007 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 19 Sayı: 3
- Basım Tarihi: 2007
- Doi Numarası: 10.1016/j.jclinane.2006.10.008
- Dergi Adı: Journal of Clinical Anesthesia
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.186-191
- Anahtar Kelimeler: C-reactive protein, Cholesterol, Prognostic factor, Severe sepsis
- Trakya Üniversitesi Adresli: Evet
Özet
Study Objective: To evaluate serum C-reactive protein and cholesterol as a prognostic factor for survival in patients with severe sepsis. Design: Prospective study. Setting: University hospital. Patients: The study population consisted of 96 patients (age range, 18-75 years; median, 56 years; men/women ratio, 40:56) in whom severe sepsis was diagnosed. Interventions: Patients' serum levels of C-reactive protein and cholesterol were measured upon admission to an intensive care unit, two days later, and on the day of discharge from the intensive care unit or on the day of death. Measurements and Main Results: Cholesterol levels were significantly lower among the nonsurviving patients (day 1, 92.2 ± 25.1 mg/dL; day 2, 92.1 ± 21.7 mg/dL; death/discharge day, 92.2 ± 21.7 mg/dL) than surviving patients (day 1, 175.1 ± 38.6 mg/dL [P < 0.001]; day 2, 173.0 ± 39.3 mg/dL [P < 0.001]; death/discharge day, 171.8 ± 39.6 mg/dL [P = 0.010]). Median C-reactive protein levels were significantly higher among the nonsurvivors (day 1, 32 mg/dL [range, 20.5-64.5 mg/dL]; day 2, 33 mg/dL [range, 22-74.5 mg/dL]; death/discharge day, 30 mg/dL [range, 22-57 mg/dL]) than survivors (day 1, 10 mg/dL [range, 6-14 mg/dL]; day 2, 9 mg/dL [range, 5-10 mg/dL]; death/discharge day, 6 mg/dL [range, 3-9 mg/dL]; P < 0.001). Conclusion: Serum C-reactive protein and cholesterol are a predictor of survival in patients with severe sepsis. Low cholesterol and high C-reactive protein levels appear as a valuable tool for individual risk assessment in severe sepsis patients and for stratification of high-risk patients in future intervention trials. © 2007 Elsevier Inc. All rights reserved.